We’re exploring KLF15 agonists as a novel class of CKD therapies—regenerative, precision-driven; testing will be done in chip and patch models. #CKDResearch #KLF15 #DeSci
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.
